Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

SALL4 Polyclonal antibody

SALL4 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, IP, CoIP, ELISA

DRRS, HSAL4, Sal like protein 4, Sal-like protein 4, Zinc finger protein 797

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
CoraLite® Plus 488
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for SALL4 in ?

Tested Applications

Positive WB detected inHepG2 cells
Positive IP detected inHepG2 cells
Positive IHC detected inmouse testis tissue, human ovary tumor tissue, human testis tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inCaco-2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:250-1:1000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

24500-1-AP targets SALL4 in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag17480

Product name: Recombinant human SALL4 protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 1-350 aa of BC111714

Sequence: MSRRKQAKPQHINSEEDQGEQQPQQQTPEFADAAPAAPAAGELGAPVNHPGNDEVASEDEATVKRLRREETHVCEKCCAEFFSISEFLEHKKNCTKNPPVLIMNDSEGPVPSEDFSGAVLSHQPTSPGSKDCHRENGGSSEDMKEKPDAESVVYLKTETALPPTPQDISYLAKGKVANTNVTLQALRGTKVAVNQRSADALPAPVPGANSIPWVLEQILCLQQQQLQQIQLTEQIRIQVNMWASHALHSSGAGADTLKTLGSHMSQQVSAAVALLSQKAGSQGLSLDALKQAKLPHANIPSATSSLSPGLAPFTLKPDGTRVLPNVMSRLPSALLPQAPGSVLFQSPFST

Predict reactive species
Full Name sal-like 4 (Drosophila)
Calculated Molecular Weight 1053 aa, 112 kDa
Observed Molecular Weight 66-75 kDa
GenBank Accession NumberBC111714
Gene Symbol SALL4
Gene ID (NCBI) 57167
RRIDAB_2879576
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9UJQ4
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Sal-like protein 4 (SALL4), also named Zinc finger protein 797, contains 7 C2H2-type zinc fingers and belongs to the sal C2H2-type zinc-finger protein family. SALL4 is a transcription factor that exists in two splice isoforms and regulates transcription in embryonic stem cells, hematopoiesis, and acute myeloid leukemia. SALL4 is activated in fetal liver tissue, silenced in adult liver tissue, and reexpressed as an oncofetal protein in hepatocellular carcinoma (PMID: 26892498, 23758232). SALL4 has two isoforms with predicted molecular weights of 112 kDa (SALL4A) and 66 kDa (unmodified SALL4B), and SALL4B was found to be the dominant endogenous isoform in HCC cell lines. Ectopically expressed SALL4B migrated at 95 kDa modified by ubiquitination, 130 kDa modified by sumoylation (PMID: 23012367).

Protocols

Product Specific Protocols
IF protocol for SALL4 antibody 24500-1-APDownload protocol
IHC protocol for SALL4 antibody 24500-1-APDownload protocol
IP protocol for SALL4 antibody 24500-1-APDownload protocol
WB protocol for SALL4 antibody 24500-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

SALL4 Polyclonal Antibody (cat. no. 24500-1-AP) has 16 total citations. Papers appear in journals including J Exp Clin Cancer Res, Cell Death Dis, Int J Mol Med, J Med Chem, Sci Rep, Cell Signal, Technol Cancer Res Treat, J Mol Histol, Onco Targets Ther, Pathol Int, and J Morphol. Research fields span oncology (colorectal, breast, hepatocellular, laryngeal, prostate, and oral squamous cell cancers), cancer stem cells, drug resistance/radiosensitivity, molecular degrader discovery, intestinal/ulcerative colitis, and organismal regeneration. Applications cited include WB, IHC, IF, and CoIP in human and mouse samples.

SpeciesApplicationTitle
humanWB

J Exp Clin Cancer Res

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.

Authors - Chaoqun Liu
humanCoIP

Cell Death Dis

SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification

Authors - Junhong Huang
mouseWB

Int J Mol Med

Integrative transcriptomic analysis unveils FXR as a key regulator of intestinal stemness and inflammation in ulcerative colitis.

Authors - Ao Lin
humanWB

J Med Chem

Novel Highly Potent c-Met Degraders against a Broad Range of Cancers

Authors - Changkai Jia
humanWB

J Med Chem

Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders

Authors - Yanqing Zhang
humanWB

J Med Chem

Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer Immunotherapy.

Authors - Yalei Wang
Loading...
||
New chat

Able®

正在加载,请稍候...